tracking
Rate this Video

Approval of New Drug Rytary for Parkinson's Disease

On Jan 8, 2015, RYTARY, an extended release formulation of carbidopa/levodopa, was approved by the FDA for the treatment of Parkinson's disease. What does it mean for people with Parkinson's disease? James Beck, PhD, Vice President, Scientific Affairs at the Parkinson's Disease Foundation explains.
Link
Embed
Email
Comments (0)
Add your comment